FIGS | Ticker Profile - Titan Protect

FIGS

FIGS, Inc.

Consumer Cyclical · Apparel Manufacturing · NYQ

$11.87

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$2.1B

Total market value of the company

Trailing P/E

57.82

Expensive — high growth expected

Forward P/E

39.60

Based on estimated future earnings — lower means cheaper

Rev Growth

+28.0%

Year-over-year revenue change

Profit Margin

6.1%

How much profit the company keeps from each dollar of revenue

ROE

10.0%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$17.00

+43% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 8 analysts covering this stock

About FIGS, Inc.

FIGS, Inc., together with its subsidiary, FIGS Canada, Inc., operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. The company designs and sells scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. It also offers sports apparel, performance leggings and tops, super-soft pima cotton tops, vests, fleeces, and jackets; and necessities comprising scrub caps, lanyards, badge reels, bags, baseball caps, and beanies. The company markets and sells its products to healthcare professionals through its direct-to-consumer digital platform comprising website, mobile app, and B2B business, as well as retail stores. FIGS, Inc. was incorporated in 2013 and is headquartered in Santa Monica, California.

https://www.wearfigs.com

Country: United States Employees: 330 Industry: Apparel Manufacturing

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

DISTRIBUTION

Smart money appears to be selling into strength — caution

Sharpe Ratio

0.984

Good returns relative to risk taken

Kelly Fraction

0.0502

Suggested allocation is meaningful — the edge justifies a position

Calmar Ratio

1.136

Returns exceed worst-case losses — strong risk profile

Annual Return

53.5%

Historical annualised return based on price data

Max Drawdown

-47.1%

Largest peak-to-trough decline — the worst it has been

HMM State

CRISIS

Elevated risk detected — extreme caution warranted

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.12

Moves slightly more than the broader market

52W High

$17.48

32% below the year high

52W Low

$4.25

179% above the year low

Avg Volume

3,489,370

Average daily shares traded — higher means easier to buy and sell

Short Ratio

3.5

Days it would take all short sellers to cover — higher means more crowded

Short % Float

14.5%

Elevated short interest — bears are positioned against this

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$0.22

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

14.07

Heavy leverage — higher financial risk if revenues decline

Current Ratio

5.39

Strong balance sheet — comfortably covers short-term obligations

Quick Ratio

3.52

Like current ratio but excludes inventory — stricter test

Gross Margin

66.6%

Revenue left after cost of goods — higher means pricing power

Operating Margin

2.8%

Profit from core operations before interest and tax

Free Cash Flow

$29M

Positive — the business generates more cash than it spends

Revenue (TTM)

$666M

Total revenue over the last 12 months

Net Income

$41M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$22.00

Target Median

$17.00

Target Low

$14.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go